89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 69 filers reported holding 89BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,364,453 | -22.1% | 217,905 | -4.4% | 0.00% | 0.0% |
| Q2 2023 | $4,320,960 | +526.6% | 228,019 | +403.6% | 0.00% | – |
| Q1 2023 | $689,569 | +100.0% | 45,277 | +67.2% | 0.00% | – |
| Q4 2022 | $344,767 | +259.1% | 27,083 | +64.1% | 0.00% | – |
| Q3 2022 | $96,000 | -17.2% | 16,503 | -46.1% | 0.00% | – |
| Q1 2022 | $116,000 | -71.8% | 30,632 | -2.5% | 0.00% | – |
| Q4 2021 | $411,000 | -31.5% | 31,431 | +2.5% | 0.00% | – |
| Q3 2021 | $600,000 | +12.6% | 30,659 | +7.4% | 0.00% | – |
| Q2 2021 | $533,000 | +4.9% | 28,547 | +33.0% | 0.00% | – |
| Q1 2021 | $508,000 | -8.8% | 21,458 | -6.2% | 0.00% | – |
| Q4 2020 | $557,000 | +36.9% | 22,867 | +44.1% | 0.00% | – |
| Q3 2020 | $407,000 | +65.4% | 15,865 | +62.9% | 0.00% | – |
| Q1 2020 | $246,000 | – | 9,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
| Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
| Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
| Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
| Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
| Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
| Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
| Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |